Intrinsiqs

Is McKesson Corporation overvalued?

McKesson Corporation (MCK) looks overvalued — trading about 22% above its fair value.

Overvalued
Current price $878.73 Fair value $688.96
Price
$878.73
Fair value
$688.96
Current P/E
22.9
Normal P/E
18.0
Market cap
$102.88B
Dividend yield
0.4%
Return on equity
-194.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MCK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.